Elizabeth Lucas

Elizabeth Lucas is a correspondent for Kaiser Health News, who specializes in data analysis and reporting.

Latest from Elizabeth Lucas

News

Environment & Health

Pharma Cash Rolls Into Congress to Defend an Embattled Industry

Mitch McConnell, who is running for reelection, has seen an uptick in pharmaceutical industry donations this year.

by: Emmarie Huetteman,; Jay Hancock &; Elizabeth Lucas,; Kaiser Health News

August 28, 2019

News

Environment & Health

Big Pharma Gave Money to Patient Advocacy Groups Opposing Medicare Changes

About half of the groups representing patients have received funding from the pharmaceutical industry.

by: Sydney Lupkin,; Elizabeth Lucas &; Victoria Knight,; Kaiser Health News

March 8, 2019

Environment & Health

How a Drug Company Under Pressure for High Prices Ratchets Up Political Activity

As scrutiny of its soaring insulin prices escalated and drove its stock down, the pharma giant Novo Nordisk aggressively ratcheted up spending to spread its influence in Washington.

by: Jay Hancock &; Elizabeth Lucas,; Kaiser Health News

May 2, 2018

Environment & Health

Patient Advocacy Groups Take in Millions From Drugmakers. Is There a Payback?

A new database tallies money from Big Pharma to patient groups.

by: Emily Kopp,; Sydney Lupkin &; Elizabeth Lucas,; Kaiser Health News

April 13, 2018

News

Economy & Labor

Follow the Money: Drugmakers Deploy Political Cash as Prices and Anger Mount

Despite running into trouble this year, drugmaker, Mallinckrodtt, has been increasing its lobbying efforts in Congress.

by: Jay Hancock,; Elizabeth Lucas &; Sydney Lupkin,; Kaiser Health News

July 28, 2017